Newbridge Financial Services Group’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
Newbridge Financial Services Group's WST Position: Q3 2026 in Review
Newbridge Financial Services Group held its West Pharmaceutical (WST) position steady in Q3 2026 at 17 shares worth $6.35K. The position accounts for ﹤0.01% of the portfolio, ranked #919.
Newbridge Financial Services Group first reported a position in WST in Q3 2020 and has held it in 18 quarters since. The position peaked at $111K in Q1 2025. 881 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- Newbridge Financial Services Group held 17 shares of West Pharmaceutical worth $6.35K as of Q3 2026.
- Newbridge Financial Services Group left its West Pharmaceutical share count unchanged in Q3 2026.
- West Pharmaceutical made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q3 2026, its #919 holding.
- Newbridge Financial Services Group first reported a position in West Pharmaceutical in Q3 2020 and has held it in 18 quarters since.
- Newbridge Financial Services Group's West Pharmaceutical position peaked at $111K in Q1 2025.
- 881 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on Newbridge Financial Services Group's 13F filing for Q3 2026, filed 15 Oct 2026.